Our PDX model also indicated that EGFR-TKI resistant cells show a higher pAKT expression (lower expression of EGFR) compared to EGFR-TKI sensitive cells (higher expression of EGFR), supporting the relevance to pathological situations of human NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.